NextCure, Inc., a newly formed biopharmaceutical company focused on the discovery and development of new immuno-oncology products, raised $67m in Series A financing. Backers included Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer, Sofinnova Ventures, and Alexandria Venture Investments. In…